Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media › C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
03/2003
03/27/2003WO2002005857A3 Phosphatonin-related gene and methods of use thereof
03/27/2003WO2002002737A3 High-throughput method for examining the effects of membrane-impermeable compounds that contain no gene
03/27/2003WO2002000692A3 Pd-l2 molecules: pd-1 ligands and uses therefor
03/27/2003WO2001098520A8 Transgenically produced platelet derived growth factor
03/27/2003WO2001098469A3 Polypeptides having peroxidase activity and nucleic acids encoding same
03/27/2003WO2001092548A3 Vaccine and gene therapy vector and methods of use thereof
03/27/2003WO2001083794A3 Dna transfection system for the generation of infectious influenza virus
03/27/2003WO2001079419A3 Cellular arrays for the identification of altered gene expression
03/27/2003WO2001077390A3 Process for allele discrimation utilizing primer extension
03/27/2003WO2001062954A3 Stearoyl-coa desaturase to identify triglyceride reducing therapeutic agents
03/27/2003WO2001061346A3 Methods for identifying agents causing a lethal phenotype
03/27/2003US20030061638 Method for regulating cell death
03/27/2003US20030061637 Polynucleotides for root trait alteration
03/27/2003US20030061636 Nucleotide sequences coding polypeptide for use in the generation of stress and tolerance resistant plants
03/27/2003US20030061635 Nucleotide sequences coding protein for use in controlling physiological responses in plants
03/27/2003US20030061634 Sucrose-binding proteins
03/27/2003US20030061633 Nucleotide sequences coding dihydrodipicolinate synthase for use in generation of amino acids for use in animal feeds and nutrients
03/27/2003US20030061629 Production of transgenic birds using stage X primordial germ cells
03/27/2003US20030061628 Nucleotide sequences coding polypeptide for use in controlling gene expression and treating genetic disotders
03/27/2003US20030061627 Polynucleotide
03/27/2003US20030061626 Characterisation of gene function using double stranded RNA inhibition
03/27/2003US20030061625 Modulation of PDE11A activity
03/27/2003US20030060620 Methods and apparatus for the recovery of nucleic acids
03/27/2003US20030060619 Antibody for use in the disgnosis and treatment of kidney, urogenital, and sex disorders
03/27/2003US20030060616 Type II IL-1 receptors
03/27/2003US20030060615 Novel Bak binding protein, DNA encoding the protein, and methods of use thereof
03/27/2003US20030060614 Family of immunoregulators designated leukocyte immunoglobulin-like receptors (LIR)
03/27/2003US20030060613 Protein for use in the treatment of bone, tumor and inflammatory disorders
03/27/2003US20030060443 Inhibition of apoptosis by the expression of antisense RNA of caspase-3
03/27/2003US20030060439 Hypoxia responsive transcription enhancer element from yeast
03/27/2003US20030060438 Adminstering oligonucleotides or analogs that are complementary to a portion of nucleic acid in the nk-1 receptor biosynthetic pathway to the extent that production is modulated
03/27/2003US20030060437 Antisense modulation of dual specific phosphatase 5 expression
03/27/2003US20030060436 Treatment of parkinson's disease with oligonucleotides
03/27/2003US20030060433 Reducing the severity of cancer
03/27/2003US20030060432 Antagonists of the oncogenic activity of the protein mdm2, and use thereof in the treatment of cancers
03/27/2003US20030060417 Novel gene having reverse transcriptase motif
03/27/2003US20030060416 Blk genes, gene products and uses thereof in apoptosis
03/27/2003US20030060410 Use of HMG fragments as anti-inflammatory agents
03/27/2003US20030060407 Secreted and transmembrane polypeptides and nucleic acids encoding the same
03/27/2003US20030060401 Genetic engineered drug
03/27/2003US20030060399 A heat shock protein 20 (HSP20)-derived polypeptides for treating or inhibiting smooth muscle vasospasm, smooth muscle cell proliferation, migration, and vasoconstriction
03/27/2003US20030059945 Electroporation apparatus for use in the treatment of blood disorders
03/27/2003US20030059944 Method for expression of small antiviral RNA molecules within a cell
03/27/2003US20030059943 Inhibition of gene expression in preferential cell; obtain cells, infect with viral particles, recover infected cells, express viral sequences, monitor adjustment in gene expression
03/27/2003US20030059942 Enhanced transfection system
03/27/2003US20030059941 Transduction of bone marrow stromal cells; obtain cells, incubate with retroviral vector coding preferential enzymatic polypeptides, recover transform cell and monitor cell activity; for use as treatment of parkinson's disease
03/27/2003US20030059940 Methods for delivering nucleic acid molecules into cells and assessment thereof
03/27/2003US20030059938 Presenilin-deficient multipotent cell lines and screening methods for intramembrane-regulated proteolytic activities using these lines
03/27/2003US20030059937 Antibodies that immunospecifically bind BLyS
03/27/2003US20030059936 Method and apparatus for intracellular manipulation of a biological cell
03/27/2003US20030059934 Artificial chromosomes comprising EHV sequences
03/27/2003US20030059925 Fermentation medium and method
03/27/2003US20030059924 Cloning of a novel inhibitor of antigen-receptor signaling by a retroviral-based functional screen
03/27/2003US20030059922 Sphingosine1-phosphate lyase polypeptides, polynucleotides and modulating agents and methods of use therefor
03/27/2003US20030059921 Novel clot-specific steptokinase proteins possessing altered plasminogen activation characteristics and a process for the preparation of said proteins
03/27/2003US20030059916 IRAK-4: compositions and methods of use
03/27/2003US20030059914 Microorganismal culture for use in the generation of transglutaminases; for use in food processing and cosmetics
03/27/2003US20030059913 Novel Microorganisms with ability to degrade indole and novel enzymes therefrom
03/27/2003US20030059909 Nucleotide sequences coding polypeptide for use in the diagnosis, prevention and treatment of cell proliferative disorders
03/27/2003US20030059904 Process for producing l-amino acids via fermentation method
03/27/2003US20030059900 Kit for use in the transfer and exchange of genetic material
03/27/2003US20030059898 Expression vector for use as gene transfer tool in genetic engineering
03/27/2003US20030059894 Nucleotide sequences coding polypeptide for use in the treatment, prevention and diagnosis of lyme disease
03/27/2003US20030059890 Protein for use as antiinflammatory, antiproliferative and antipyretic agents
03/27/2003US20030059888 Vector for use as gene transfer and diagnostic tool in genetic enginering
03/27/2003US20030059887 Ligand for use in the treatment of tumors, injuries, thrombosis, atherosclerosis and inflammatory diseases
03/27/2003US20030059886 Nucleotide sequences coding polypeptide for use in the treatment diagnosis and prevention of tumor and cell proliferative disorders
03/27/2003US20030059885 Nucleotide sequences coding polypeptide for use in the treatment diagnosis and prevention of tumor and cell proliferative disorders
03/27/2003US20030059883 Secreted and transmembrane polypeptides and nucleic acids encoding the same
03/27/2003US20030059882 Secreted and transmembrane polypeptides and nucleic acids encoding the same
03/27/2003US20030059880 Secreted and transmembrane polypeptides and nucleic acids encoding the same
03/27/2003US20030059879 Secreted and transmembrane polypeptides and nucleic acids encoding the same
03/27/2003US20030059877 Human cystine knot polypeptide
03/27/2003US20030059875 Nucleotide sequences coding polypeptide for use in the treatment prevention and diagnosis of inflammatory blood and cancer disorders
03/27/2003US20030059874 Polypeptide for use in the treatment of autoimmune, inflammatatory, arthritic, atherosclerotic, allergenic, dermatitis, urticaria, adult respiratory distress syndrome, asthma, rhinitis, eczema and infections
03/27/2003US20030059873 Hepatitis virus for use in the diagnosis and prevention of viral diseases in birds and humans
03/27/2003US20030059872 Nucleotide sequences coding polypeptide for use as diagnostic tools in genetic engineering
03/27/2003US20030059871 Hematopoietin receptors HPR1 and HPR2
03/27/2003US20030059870 Expression vector for use as gene transfer and modification tool in genetic engineering
03/27/2003US20030059869 Novel G protein-coupled receptor, GAVE3
03/27/2003US20030059868 Retinal cell lines with extended life-span and their applications
03/27/2003US20030059866 Isolation and cultivation of microorganisms from natural environments and drug discovery based thereon
03/27/2003US20030059862 Antibodies against tumor necrosis factor delta (APRIL)
03/27/2003US20030059861 Nucleotide sequences which code membrane protein for use in the treatment of respiratory system disorders
03/27/2003US20030059860 Antibody for use in the classification and detection of parasitic infection of mammals
03/27/2003US20030059859 Vertebrate protein for use in human therapeutic and diagnostics
03/27/2003US20030059858 Detection and classification of transcription factors; obtain cells, homogenize, extract protein, screen fractions for transcriptional activity
03/27/2003US20030059856 Detection of modulator of receptor binding activity; obtain sample containing receptor, incubate with test agent and ligand, monitor binding activity of ligand, adjusment in binding activity indicates modulator
03/27/2003US20030059852 Detecting modulators of integrin activity; obtain sample containing integrin, incubate with test compound, monitor adjustment in integrin activity, adjustment in integrin activity indicates modulator
03/27/2003US20030059845 Novel human dopamine receptor and its uses
03/27/2003US20030059835 Nucleotide sequence coding red fluorescent protein for use as diagnostic tool in genetic analysis
03/27/2003US20030059834 Generating monoclonal antibodies; obtain nucleotide sequences from library, clone, transduce or transfect cells, isolate lymphocyte, recover monoclonal abtibodies
03/27/2003US20030059833 Nucleotide sequences coding polypeptide for use in the treatment and preventon of tumors and nervous system disorders
03/27/2003US20030059832 Nucleotide sequences coding polypeptide for use in the treatment and preventon of tumors and nervous system disorders
03/27/2003US20030059831 Nucleotide sequences coding polypeptide for use in the treatment and preventon of tumors and nervous system disorders
03/27/2003US20030059825 Tumor suppressor gene del-27
03/27/2003US20030059822 Differential tagging of polymers for high resolution linear analysis
03/27/2003US20030059821 Biosensor surface for immobilizing and analyzing a physiologically active substance
03/27/2003US20030059817 Inkjet method of spotting probe and manufacturing a probe array
03/27/2003US20030059812 HDAC9 polypeptides and polynucleotides and uses thereof
1 ... 2558 2559 2560 2561 2562 2563 2564 2565 2566 2567 2568 2569 2570 2571 2572 2573 2574 2575 2576 2577 2578 ... 4023